-transparent.png){kind=logo}
Modification of DNA and double-stranded deoxyoligonucleotides with antitumour 1,2-diamino-cyclohexanedinitroplatinum(II) (Pt-dach) complexes was investigated with the aid of physico-chemical methods and chemical probes of nucleic acid conformation. The three Pt-dach complexes were used which differed in isomeric forms of the dach nonleaving ligand-Pt(1R,2R-dach), Pt(1S,2S-dach) and Pt(1R,2S-dach) complexes. The latter complex has lower antitumour activity than the other two Pt-dach complexes. Pt(1R,2S-dach) complex exhibits the slowest kinetics of its binding to DNA and of the conversion of monofunctional binding to bifunctional lesions. The anomalously slow electrophoretic mobility of multimers of the platinated and ligated oligomers suggests that bifunctional binding of Pt-dach complexes to a d(GG) site within double-stranded oligonucleotides induces bending of the oligomer. In addition, chemical probing of double-helical deoxyoligonucleotides modified by the Pt-dach complexes at the d(GG) sites reveals that Pt(1R,2S-dach) complex induces more extensive conformational changes in the oligomer than Pt(1R,2R-dach) and Pt(1S,2S-dach) complexes. It is proposed that different effects of the Pt-dach complexes on DNA observed in this work arise mainly from a steric crowding of the axially oriented cyclohexane ring in the DNA adduct of Pt(1R,2S-dach) complex.
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
April 1987,
Journal of medicinal chemistry,
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
January 1993,
Journal of cancer research and clinical oncology,
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
January 1996,
Cancer chemotherapy and pharmacology,
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
January 1994,
Journal of cancer research and clinical oncology,
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
March 1974,
Research communications in chemical pathology and pharmacology,
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
November 1981,
Cancer research,
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
April 1994,
Journal of inorganic biochemistry,
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
October 1985,
Cancer research,
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
March 1990,
Journal of medicinal chemistry,
V Boudný, and
O Vrána, and
F Gaucheron, and
V Kleinwachter, and
M Leng, and
V Brabec
December 1986,
Cancer research,
